Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants - Report - MDSpire

Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants

  • By

  • Nurun N. Fancy

  • Nanet Willumsen

  • Vicky M. N. Chau

  • Samuel L. Boulger

  • Harry J. Whitwell

  • Wenhao Wang

  • Baptiste Avot

  • Michael Thomas

  • Jonathan Talbot-Martin

  • Stergios Tsartsalis

  • Combiz Khozoie

  • Aisling McGarry

  • Eleonore Schneegans

  • Riad Yagoubi

  • To Ka Dorcas Cheung

  • Marianna Papageorgopoulou

  • Emily Adair

  • Benjamin Cooper

  • Karen Davey

  • Amy M. Smith

  • William Scotton

  • John Hardy

  • Paul M. Matthews

  • Johanna S. Jackson

  • June 15, 2026

  • 0 min

Share

Clinical Report: Pathological Mechanisms of Alzheimer’s Disease Associated with TREM2 Variants

Overview

This study investigates the pathological mechanisms associated with TREM2 variants R47H and R62H in Alzheimer's disease (AD). It highlights the differential genetic risks conferred by these variants and their impact on microglial, astrocytic, and neuronal interactions in AD pathology.

Background

Alzheimer's disease is a complex neurodegenerative disorder with significant genetic components influencing its onset and progression. Variants in the TREM2 gene have been linked to increased risk for late-onset AD, particularly the R47H and R62H variants. Understanding the mechanisms by which these variants affect cellular interactions in the brain is crucial for developing targeted therapies and improving patient outcomes.

Data Highlights

This study utilized immunohistochemistry and imaging mass cytometry to analyze brain samples from individuals with and without Alzheimer's disease, focusing on the impact of TREM2 variants on β-amyloid pathology.

Key Findings

  • The R47H variant confers a significantly higher relative risk for AD compared to the common variant alleles.
  • Both TREM2 variants (R47H and R62H) are associated with increased neuronal loss in post-mortem AD tissue.
  • Microglial pathology differs based on TREM2 genotype, influencing astrocytic and neuronal responses in AD.
  • Reduced β-amyloid clearance is observed in models with TREM2 knockout or the R47H variant.
  • CD33 variants may interact with TREM2, affecting microglial function and AD risk.

Clinical Implications

Clinicians should consider the genetic background of patients when assessing AD risk and pathology. Understanding the role of TREM2 variants can guide therapeutic strategies aimed at modulating microglial and neuronal interactions in Alzheimer's disease.

Conclusion

The findings underscore the importance of TREM2 variants in the pathogenesis of Alzheimer's disease, highlighting their role in microglial and neuronal interactions that contribute to disease progression.

Related Resources & Content

  1. Acta Neuropathologica, 2023 -- Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants
  2. Acta Neuropathologica, 2021 -- Expression of TREM2 in the Central Nervous System and Biological Fluids in Prion Disorders
  3. Acta Neuropathologica, 2023 -- Regional Variations in TREM2 Gene Expression Linked to Alzheimer’s Disease Neuropathology
  4. Acta Neuropathologica, 2024 -- Transcriptional Landscape of Myeloid Cells in the Brain During the Spatiotemporal Development of Alzheimer’s Disease
  5. The Alzheimer's Association Clinical Practice Guideline for the Diagnostic Evaluation, Testing, Counseling and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD), 2024
  6. Acta Neuropathologica — Exploring the Evolving Genetic Framework of Alzheimer’s Disease: Transitioning from the Amyloid Cascade to the Hypothesis of Genetically Induced Synaptic Dysfunction
  7. Lecanemab in Early Alzheimer’s Disease
  8. The Alzheimer's Association Clinical Practice Guideline for the Diagnostic Evaluation, Testing, Counseling and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Alzheimer's & Dementia
  9. Mechanisms of increased Alzheimer’s disease pathology with R47H and R62H TREM2 variants | Acta Neuropathologica | Springer Nature Link

Original Source(s)

Related Content